ATE442134T1 - Multipartikuläre verabreichungsformen von propranolol mit zeitgesteuerter und verlängerter wirkstofffreigabe - Google Patents

Multipartikuläre verabreichungsformen von propranolol mit zeitgesteuerter und verlängerter wirkstofffreigabe

Info

Publication number: ATE442134T1
Authority: AT; Austria
Prior art keywords: propranolol; pharmaco; release; multiparticular; timed
Prior art date: 2001-10-04

Application number

AT02766476T

Other languages

English (en)

Inventor

Phillip Percel

Gopi Venkatesh

Krishna Vishnupad

Original Assignee

Eurand Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-04

Filing date

2002-10-02

Publication date

2009-09-15

2002-10-02 Application filed by Eurand Inc filed Critical Eurand Inc

2009-09-15 Application granted granted Critical

2009-09-15 Publication of ATE442134T1 publication Critical patent/ATE442134T1/de

Links

AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 title abstract 4
229960003712 propranolol Drugs 0.000 title abstract 2
238000013265 extended release Methods 0.000 title 1
239000011324 bead Substances 0.000 abstract 2
230000027288 circadian rhythm Effects 0.000 abstract 2
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
239000002327 cardiovascular agent Substances 0.000 abstract 1
229940125692 cardiovascular agent Drugs 0.000 abstract 1
230000002060 circadian Effects 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
238000012377 drug delivery Methods 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000008188 pellet Substances 0.000 abstract 1
230000003285 pharmacodynamic effect Effects 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Detergent Compositions (AREA)

AT02766476T 2001-10-04 2002-10-02 Multipartikuläre verabreichungsformen von propranolol mit zeitgesteuerter und verlängerter wirkstofffreigabe ATE442134T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/971,167 US6500454B1 (en)	2001-10-04	2001-10-04	Timed, sustained release systems for propranolol
PCT/US2002/031535 WO2003028708A1 (en)	2001-10-04	2002-10-02	Timed, sustained release multi-particulate dosage forms of propranolol

Publications (1)

Publication Number	Publication Date
ATE442134T1 true ATE442134T1 (de)	2009-09-15

Family

ID=25518009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02766476T ATE442134T1 (de)	2001-10-04	2002-10-02	Multipartikuläre verabreichungsformen von propranolol mit zeitgesteuerter und verlängerter wirkstofffreigabe

Country Status (12)

Country	Link
US (2)	US6500454B1 (de)
EP (1)	EP1432411B1 (de)
JP (1)	JP4369752B2 (de)
KR (1)	KR101090719B1 (de)
AT (1)	ATE442134T1 (de)
AU (1)	AU2002330211B2 (de)
CA (1)	CA2462637C (de)
DE (1)	DE60233668D1 (de)
ES (1)	ES2333306T3 (de)
MX (1)	MXPA04003234A (de)
NO (1)	NO335070B1 (de)
WO (1)	WO2003028708A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8071128B2 (en)	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6500454B1 (en) *	2001-10-04	2002-12-31	Eurand Pharmaceuticals Ltd.	Timed, sustained release systems for propranolol
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
US8367111B2 (en) *	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
US7967756B2 (en) *	2003-09-18	2011-06-28	Cardiac Pacemakers, Inc.	Respiratory therapy control based on cardiac cycle
US7387793B2 (en) *	2003-11-14	2008-06-17	Eurand, Inc.	Modified release dosage forms of skeletal muscle relaxants
US20050142203A1 (en) *	2003-12-30	2005-06-30	Grant Heinicke	Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same
US20060003001A1 (en) *	2004-02-11	2006-01-05	John Devane	Chronotherapeutic compositions and methods of their use
JP2005306778A (ja) *	2004-04-21	2005-11-04	Basf Ag	徐放性製剤及びその製造方法
US8747895B2 (en)	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US20060173081A1 (en) *	2004-10-01	2006-08-03	Rotenberg Keith S	Treating morning migraines with propranolol
WO2006042249A2 (en) *	2004-10-08	2006-04-20	Neuromolecular Pharmaceuticals, Inc.	Methods and compositions for treating migraine pain
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
WO2006047493A2 (en)	2004-10-21	2006-05-04	Eurand Pharmaceuticals Limited	Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060099258A1 (en) *	2004-11-05	2006-05-11	Grant Heinicke	Propranolol formulations
US20060099259A1 (en) *	2004-11-05	2006-05-11	Grant Heinicke	Propranolol formulations
US20060182806A1 (en) *	2004-11-08	2006-08-17	Mintong Guo	Extended-release propranolol composition
US8058291B2 (en)	2005-04-06	2011-11-15	Adamas Pharmaceuticals, Inc.	Methods and compositions for the treatment of CNS-related conditions
US7619007B2 (en)	2004-11-23	2009-11-17	Adamas Pharmaceuticals, Inc.	Method and composition for administering an NMDA receptor antagonist to a subject
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
AU2013273835B2 (en) *	2005-05-02	2016-07-07	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
US11311490B2 (en)	2005-08-10	2022-04-26	Add Advanced Drug Delivery Technologies Ltd.	Oral preparation with controlled release
US20070196491A1 (en) *	2006-01-27	2007-08-23	Eurand, Inc.	Drug delivery systems comprising weakly basic drugs and organic acids
JP5433236B2 (ja) *	2006-01-27	2014-03-05	アプタリスファーマテック，インコーポレイテッド	弱塩基性選択性セロトニン５−ｈｔ３遮断剤および有機酸を含む薬物送達系
BRPI0707736A2 (pt) *	2006-02-13	2011-05-10	Vanda Pharmaceuticals Inc	formulaÇÕes de imidazolilalquil-piridinas de dosagem estÁvel
US8846100B2 (en) *	2006-05-12	2014-09-30	Shire Llc	Controlled dose drug delivery system
CA2653209A1 (en) *	2006-05-26	2007-12-06	Auspex Pharmaceuticals, Inc.	Deuterated aminoglycidyl compounds
NZ575171A (en) *	2006-08-31	2012-04-27	Aptalis Pharmatech Inc	Drug delivery systems comprising solid solutions of weakly basic drugs
WO2008027557A2 (en) *	2006-08-31	2008-03-06	Spherics, Inc.	Topiramate compositions and methods of enhancing its bioavailability
EP2394643B1 (de)	2006-11-17	2015-09-02	Supernus Pharmaceuticals, Inc.	Topiramat-Formulierungen mit verzögerter Freisetzung
EP2363113B1 (de) *	2006-12-04	2017-08-02	Supernus Pharmaceuticals, Inc.	Topiramat-Formulierungen für verstärkte unmittelbare Freisetzung
US20080187579A1 (en) *	2007-02-01	2008-08-07	Pavan Bhat	Extended-release dosage form
WO2008115797A1 (en) *	2007-03-16	2008-09-25	Pavo, Inc.	Therapeutic compositions and methods
EP2222300B1 (de)	2007-12-13	2014-06-11	Vanda Pharmaceuticals Inc.	Verfahren und zusammensetzung zur behandlung eines zustands, der durch den serotonin-rezeptor vermittelt wird
EP2222301B1 (de) *	2007-12-13	2014-10-08	Vanda Pharmaceuticals Inc.	Verfahren und zusammensetzung zur behandlung einer erkrankung, die durch den alpha-adrenozeptor vermittelt wird
US20110311626A1 (en) *	2009-02-23	2011-12-22	Gopi Venkatesh	Controlled release compositions comprising anti-cholinergic drugs
MX337603B (es)	2009-11-30	2016-03-10	Adare Pharmaceuticals Inc	Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion.
SG10201407965XA (en)	2009-12-02	2015-02-27	Aptalis Pharma Ltd	Fexofenadine microcapsules and compositions containing them
US20110142889A1 (en) *	2009-12-16	2011-06-16	Nod Pharmaceuticals, Inc.	Compositions and methods for oral drug delivery
NZ611467A (en)	2010-12-02	2015-06-26	Aptalis Pharmatech Inc	Rapidly dispersing granules, orally disintegrating tablets and methods
US20160143864A1 (en) *	2013-07-09	2016-05-26	Sun Pharmaceutical Industries Limited	Extended-release pharmaceutical compositions of metoprolol
CN105287394A (zh) *	2015-11-19	2016-02-03	哈尔滨圣吉药业股份有限公司	一种盐酸普萘洛尔缓释微丸及其制备方法
US20190060287A1 (en)	2017-08-28	2019-02-28	Adare Pharmaceuticals, Inc.	Tizanidine formulations
JP2019052115A (ja) *	2017-09-15	2019-04-04	国立研究開発法人理化学研究所	医薬組成物
GB2628566A (en)	2023-03-29	2024-10-02	Novumgen Ltd	An orally rapidly disintegrating tablet of propranolol and its process of preparation

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US48A (en) *		1836-10-11		Turnout fob
GB1561204A (en) *	1977-06-01	1980-02-13	Ici Ltd	Sustained release pharmaceutical composition
US4248857A (en) *	1979-08-09	1981-02-03	American Home Products Corporation	Sustained release pharmaceutical compositions
US4851229A (en)	1983-12-01	1989-07-25	Alza Corporation	Composition comprising a therapeutic agent and a modulating agent
US4894240A (en)	1983-12-22	1990-01-16	Elan Corporation Plc	Controlled absorption diltiazem formulation for once-daily administration
SE457505B (sv) *	1984-01-10	1989-01-09	Lejus Medical Ab	Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4728512A (en)	1985-05-06	1988-03-01	American Home Products Corporation	Formulations providing three distinct releases
GB8518301D0 (en)	1985-07-19	1985-08-29	Fujisawa Pharmaceutical Co	Hydrodynamically explosive systems
US5011692A (en)	1985-12-28	1991-04-30	Sumitomo Pharmaceuticals Company, Limited	Sustained pulsewise release pharmaceutical preparation
AU591248B2 (en)	1986-03-27	1989-11-30	Kinaform Technology, Inc.	Sustained-release pharaceutical preparation
US5238686A (en)	1986-03-27	1993-08-24	Kinaform Technology, Inc.	Sustained-release pharmaceutical preparation
IE58401B1 (en)	1986-06-20	1993-09-08	Elan Corp Plc	Controlled absorption pharmaceutical composition
US5026559A (en)	1989-04-03	1991-06-25	Kinaform Technology, Inc.	Sustained-release pharmaceutical preparation
US5133974A (en) *	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
US4983401A (en)	1989-05-22	1991-01-08	Kinaform Technology, Inc.	Sustained release pharmaceutical preparations having pH controlled membrane coatings
US5229131A (en) *	1990-02-05	1993-07-20	University Of Michigan	Pulsatile drug delivery system
IT1246382B (it) *	1990-04-17	1994-11-18	Eurand Int	Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5017381A (en)	1990-05-02	1991-05-21	Alza Corporation	Multi-unit pulsatile delivery system
IE61651B1 (en)	1990-07-04	1994-11-16	Zambon Spa	Programmed release oral solid pharmaceutical dosage form
US5286497A (en)	1991-05-20	1994-02-15	Carderm Capital L.P.	Diltiazem formulation
US5229135A (en)	1991-11-22	1993-07-20	Prographarm Laboratories	Sustained release diltiazem formulation
US5260068A (en)	1992-05-04	1993-11-09	Anda Sr Pharmaceuticals Inc.	Multiparticulate pulsatile drug delivery system
US5260069A (en)	1992-11-27	1993-11-09	Anda Sr Pharmaceuticals Inc.	Pulsatile particles drug delivery system
US5376384A (en)	1992-12-23	1994-12-27	Kinaform Technology, Inc.	Delayed, sustained-release pharmaceutical preparation
US5500227A (en) *	1993-11-23	1996-03-19	Euro-Celtique, S.A.	Immediate release tablet cores of insoluble drugs having sustained-release coating
US5536507A (en)	1994-06-24	1996-07-16	Bristol-Myers Squibb Company	Colonic drug delivery system
US6103263A (en) *	1994-11-17	2000-08-15	Andrx Pharmaceuticals, Inc.	Delayed pulse release hydrogel matrix tablet
EP0714663A3 (de)	1994-11-28	1997-01-15	Lilly Co Eli	Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
US5567441A (en)	1995-03-24	1996-10-22	Andrx Pharmaceuticals Inc.	Diltiazem controlled release formulation
US5837284A (en)	1995-12-04	1998-11-17	Mehta; Atul M.	Delivery of multiple doses of medications
TW506836B (en) *	1996-06-14	2002-10-21	Janssen Pharmaceutica Nv	Fast-dissolving galanthamine hydrobromide tablet
US5891474A (en)	1997-01-29	1999-04-06	Poli Industria Chimica, S.P.A.	Time-specific controlled release dosage formulations and method of preparing same
US5837379A (en) *	1997-01-31	1998-11-17	Andrx Pharmaceuticals, Inc.	Once daily pharmaceutical tablet having a unitary core
US6162463A (en)	1997-05-01	2000-12-19	Dov Pharmaceutical Inc	Extended release formulation of diltiazem hydrochloride
US5840329A (en)	1997-05-15	1998-11-24	Bioadvances Llc	Pulsatile drug delivery system
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
US5968554A (en)	1998-07-07	1999-10-19	Cascade Development, Inc. A Subsidiary Of Cardinal Health, Inc.	Sustained release pharmaceutical preparation
US6106862A (en) *	1998-08-13	2000-08-22	Andrx Corporation	Once daily analgesic tablet
US6039979A (en)	1999-01-13	2000-03-21	Laboratoires Prographarm	Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
US6350471B1 (en) *	2000-05-31	2002-02-26	Pharma Pass Llc	Tablet comprising a delayed release coating
US6500454B1 (en) *	2001-10-04	2002-12-31	Eurand Pharmaceuticals Ltd.	Timed, sustained release systems for propranolol

2001
- 2001-10-04 US US09/971,167 patent/US6500454B1/en not_active Expired - Lifetime
2002
- 2002-10-02 DE DE60233668T patent/DE60233668D1/de not_active Expired - Lifetime
- 2002-10-02 MX MXPA04003234A patent/MXPA04003234A/es active IP Right Grant
- 2002-10-02 JP JP2003532041A patent/JP4369752B2/ja not_active Expired - Fee Related
- 2002-10-02 EP EP02766476A patent/EP1432411B1/de not_active Expired - Lifetime
- 2002-10-02 WO PCT/US2002/031535 patent/WO2003028708A1/en not_active Ceased
- 2002-10-02 CA CA2462637A patent/CA2462637C/en not_active Expired - Lifetime
- 2002-10-02 AT AT02766476T patent/ATE442134T1/de not_active IP Right Cessation
- 2002-10-02 AU AU2002330211A patent/AU2002330211B2/en not_active Ceased
- 2002-10-02 KR KR1020047005057A patent/KR101090719B1/ko not_active Expired - Fee Related
- 2002-10-02 ES ES02766476T patent/ES2333306T3/es not_active Expired - Lifetime
- 2002-12-30 US US10/334,052 patent/US20030157173A1/en not_active Abandoned
2004
- 2004-04-28 NO NO20041740A patent/NO335070B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU2002330211B2 (en)	2007-02-01
US6500454B1 (en)	2002-12-31
US20030157173A1 (en)	2003-08-21
CA2462637A1 (en)	2003-04-10
WO2003028708A1 (en)	2003-04-10
DE60233668D1 (de)	2009-10-22
EP1432411B1 (de)	2009-09-09
NO20041740L (no)	2004-04-28
CA2462637C (en)	2010-12-07
NO335070B1 (no)	2014-09-01
EP1432411A1 (de)	2004-06-30
JP4369752B2 (ja)	2009-11-25
ES2333306T3 (es)	2010-02-19
MXPA04003234A (es)	2004-08-12
KR20040084890A (ko)	2004-10-06
JP2005508922A (ja)	2005-04-07
KR101090719B1 (ko)	2011-12-08

Legal Events

Date	Code	Title	Description
2010-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
NO20041740L (no)	2004-04-28	Tidsstyrt vedvarende frigivelses multipartikulaere doseringsformer av propranolol
PT1123700E (pt)	2004-07-30	Sistemas de libertacao de farmacos de cronometragem pulsavel
HK1047226A1 (zh)	2003-02-14	流体力学平衡口服药输送系统
BRPI0311701B8 (pt)	2021-05-25	formulação farmacêutica de dosagem multiparticulada revestida com liberação controlada de lamotrigina
DE69826113D1 (de)	2004-10-14	R- und s- enantiomere getrennteteile enthaltende dosierungsformen
WO2007090091A3 (en)	2007-11-22	Drug delivery systems comprising weakly basic drugs and organic acids
DE60334775D1 (de)	2010-12-16	Mehrstufiges orales arzneimittelsystem mit kontrollierter freisetzung
AU2003295614A8 (en)	2004-06-23	Delivery of pharmaceutical agents via the human insulin receptor
WO2004112756A8 (en)	2005-04-07	Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
PT1660037E (pt)	2011-10-24	Suspensão injectável de aripiprazol
EP0859603A4 (de)	2006-05-24	Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
EA200300847A1 (ru)	2003-12-25	Перорально вводимая система контролируемой доставки лекарственного средства, обеспечивающая временной и пространственный контроль
HRP20170746T1 (hr)	2017-08-11	Oblici davanja koji su otporni na lomljenje s odgođenim oslobađanjem
NZ521799A (en)	2004-12-24	Sustained release paracetamol composition
CA2503719A1 (en)	2004-05-21	Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases
MXPA05012810A (es)	2006-02-13	Formas de dosis oral de memantina.
Rajput et al.	2024	A current era in pulsatile drug delivery system: Drug journey based on chronobiology
HUP0500097A3 (en)	2008-04-28	Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
WO2023208241A1 (zh)	2023-11-02	一种吡非尼酮持续性释放口服固体制剂
Neupane et al.	2024	Pulsatile drug delivery system: A review
TW200500085A (en)	2005-01-01	Sustained-release pharmaceutical composition for lung administration
DeVane et al.	2001	An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacology
Sriranga et al.	2024	Controlled Drug Delivery System: A Comprehensive Review on Existing and Novel Technologies
Alsalhy et al.	2025	Sustained release of medications in liquid form: utility, advantages, and disadvantages
WO2003082342A1 (en)	2003-10-09	Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery